Skip to main content

Table 2 Prognoses after diagnosis of breast cancer by tumour characteristics and lifestyle factors

From: Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study

 

Overall survival

Disease-free survival

Death from breast cancer

Recurrence

Prognostic and lifestyle factors

Hazard ratio (95% CI)

Age, years

    

   <57

1.00

1.00

1.00

1.00

   57 to 69

1.51 (1.12 to 2.03)

1.19 (0.90 to 1.56)

1.13 (0.79 to 1.62)

0.61 (0.40 to 0.93)

   ≥69

3.20 (2.45 to 4.18)

2.25 (1.76 to 2.87)

2.05 (1.49 to 2.82)

0.56 (0.36 to 0.88)

Tumour size, mm

    

   ≤20

1.00

1.00

1.00

1.00

   20 to 50

2.39 (1.89 to 3.01)

2.12 (1.72 to 2.62)

3.27 (2.37 to 4.51)

1.49 (1.03 to 2.17)

   >50

3.48 (2.22 to 5.44)

2.44 (1.53 to 3.90)

4.27 (2.33 to 7.82)

0.95 (0.30 to 3.03)

Lymph node status

    

   Lymph node negative

1.00

1.00

1.00

1.00

   Lymph node positive

1.47 (1.18 to 1.84)

1.48 (1.21 to 1.82)

2.49 (1.81 to 3.43)

2.08 (1.41 to 3.07)

Distant metastases

    

   No

1.00

NA

1.00

NA

   Yes

8.57 (5.61 to 13.1)

NA

12.32 (7.66 to 19.80)

NA

Histopathological grade

    

   Well differentiated

1.00

1.00

1.00

1.00

   Moderately differentiated

1.64 (1.19 to 2.26)

1.57 (1.16 to 2.11)

2.52 (1.53 to 4.13)

1.94 (1.05 to 3.59)

   Poorly/un-differentiated

2.76 (1.96 to 3.90)

3.00 (2.18 to 4.12)

5.28 (3.17 to 8.79)

5.32 (2.87 to 9.87)

Estrogen receptor status

    

   Positive

1.00

1.00

1.00

1.00

   Negative

2.09 (1.63 to 2.66)

1.98 (1.57 to 2.49)

3.03 (2.24 to 4.10)

2.31 (1.54 to 3.47)

Progesterone receptor status

    

   Positive

1.00

1.00

1.00

1.00

   Negative

2.32 (1.77 to 3.05)

2.02 (1.58 to 2.60)

3.28 (2.25 to 4.77)

1.91 (1.23 to 2.95)

HER2 receptor status

    

   Positive

1.00

1.00

1.00

1.00

   Negative

2.46 (1.38 to 4.39)

2.06 (1.21 to 3.52)

2.72 (1.30 to 5.69)

1.49 (0.58 to 3.85)

No. of cigarettes smoked per day

    

   <10

1.00

1.00

1.00

1.00

   10 to 20

1.30 (0.97 to 1.75)

1.15 (0.86 to 1.54)

1.55 (1.09 to 2.21)

0.96 (0.55 to 1.66)

   ≥20

1.06 (0.74 to 1.51)

0.96 (0.68 to 1.36)

0.81 (0.49 to 1.37)

0.73 (0.37 to 1.45)

Alcohol consumption in grams per week*

    

   ≤168

1.00

1.00

1.00

1.00

   >168

0.79 (0.53 to 1.19)

0.72 (0.48 to 1.08)

0.96 (0.59 to 1.55)

0.83 (0.42 to 1.65)

Body mass index in kg/m2†

    

   <18.5

2.21 (1.37 to 3.57)

2.09 (1.31 to 3.32)

1.10 (0.48 to 2.52)

0.32 (0.04 to 2.29)

   18.5 to 24.9

1.00

1.00

1.00

1.00

   25 to 29.9

1.06 (0.80 to 1.40)

1.09 (0.84 to 1.42)

1.05 (0.74 to 1.49)

1.16 (0.74 to 1.82)

   ≥30

1.45 (1.01 to 2.09)

1.58 (1.13 to 2.21)

1.62 (1.05 to 2.52)

1.88 (1.08 to 3.25)

Menopause status, No (%)

    

Post menopause

1.00

1.00

1.00

1.00

Pre menopause

0.36 (0.26 to 0.51)

0.56 (0.42 to 0.74)

0.52 (0.36 to 0.77)

1.64 (1.12 to 2.42)

Cardiovascular disease, No (%)

    

No

1.00

1.00

1.00

1.00

Yes

2.46 (1.77 to 3.42)

2.32 (1.67 to 3.22)

1.70 (1.03 to 2.79)

1.45 (0.71 to 2.98)

  1. *Cut-off values are based on the recommendation from of the Danish National Board of Health.
  2. Body mass index was calculated as weight in kilograms divided by height in meters squared.
  3. Hazard ratios are unadjusted.
  4. NA: not applicable.